NYSE:QGEN Qiagen (QGEN) Stock Price, News & Analysis $45.54 +0.10 (+0.22%) Closing price 03:59 PM EasternExtended Trading$45.56 +0.01 (+0.03%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Qiagen Stock (NYSE:QGEN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Qiagen alerts:Sign Up Key Stats Today's Range$45.47▼$46.3750-Day Range$41.71▼$45.7552-Week Range$32.53▼$57.81Volume1.63 million shsAverage Volume2.24 million shsMarket Capitalization$9.38 billionP/E Ratio18.76Dividend Yield0.77%Price Target$43.93Consensus RatingHold Company Overview QIAGEN N.V. (NYSE:QGEN) is a global provider of sample technologies, molecular testing solutions and bioinformatics products. The company develops tools that help researchers and healthcare professionals isolate, analyze and interpret biological materials, including DNA, RNA and proteins. Its portfolio includes laboratory kits and instruments for sample preparation, polymerase chain reaction (PCR), next-generation sequencing, genotyping and molecular diagnostics. QIAGEN also provides digital and bioinformatics solutions used to manage and analyze biological data. Its products support applications in academic and pharmaceutical research, biotechnology, forensic testing, veterinary medicine and clinical healthcare. QIAGEN was founded in 1984 and has expanded from a supplier of molecular biology research tools into a global life sciences and diagnostics company. Headquartered in Venlo, the Netherlands, it serves customers through operations and distribution networks across North America, Europe, Asia and other international markets. The company is led by Chief Executive Officer Thierry Bernard.AI Generated. May Contain Errors. Read More Qiagen Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks45th Percentile Overall ScoreQGEN MarketRank™: 2.235510579575 of 5 starsQiagen scored higher than 45% of companies evaluated by MarketBeat, and ranked 506th out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingQiagen has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 1 strong buy rating, 4 buy ratings, 9 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Qiagen is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageQiagen has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Qiagen's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth7.41% Earnings GrowthEarnings for Qiagen are expected to grow by 7.41% in the coming year, from $2.43 to $2.61 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Qiagen is 23.34, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.75.Price to Earnings Ratio vs. SectorThe P/E ratio of Qiagen is 23.34, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.31.Price to Earnings Growth RatioQiagen has a PEG Ratio of 4.51. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioQiagen has a P/B Ratio of 2.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Qiagen's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.10% of the float of Qiagen has been sold short.Short Interest Ratio / Days to CoverQiagen has a short interest ratio ("days to cover") of 3.56, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Qiagen has recently increased by 0.23%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldQiagen has a dividend yield of 0.77%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthQiagen does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Qiagen is 17.95%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Qiagen will have a dividend payout ratio of 13.41% next year. This indicates that Qiagen will be able to sustain or increase its dividend.Read more about Qiagen's dividend. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 4 news articles for Qiagen this week, compared to 5 articles on an average week. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Qiagen insiders have not sold or bought any company stock.Percentage Held by Insiders9.00% of the stock of Qiagen is held by insiders.Percentage Held by Institutions70.00% of the stock of Qiagen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Qiagen's insider trading history. Receive QGEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Qiagen and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QGEN Stock News HeadlinesQIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against TuberculosisOctober 13 at 4:05 PM | businesswire.comReviewing Standard BioTools (NASDAQ:LAB) & Qiagen (NYSE:QGEN)October 11 at 7:29 AM | americanbankingnews.comBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now. Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen. Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch.October 14 at 1:00 AM | Decentralized Masters (Ad)QIAGEN Expands AI-Powered Bioinformatics for Research and Drug DiscoveryOctober 6, 2026 | businesswire.comQiagen gains on report talks with strategic buyer have advancedOctober 2, 2026 | seekingalpha.comQiagen (QGEN), What Is Behind The Fresh Attention Now?September 29, 2026 | finance.yahoo.comWhat Qiagen (QGEN)'s Expanded Sepsis Testing Portfolio Means For ShareholdersSeptember 28, 2026 | finance.yahoo.comQIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection PanelSeptember 28, 2026 | businesswire.comSee More Headlines QGEN Stock Analysis - Frequently Asked Questions How have QGEN shares performed this year? Qiagen's stock was trading at $47.3368 on January 1st, 2026. Since then, QGEN shares have decreased by 3.8% and is now trading at $45.5410. How were Qiagen's earnings last quarter? Qiagen N.V. (NYSE:QGEN) announced its earnings results on Wednesday, August, 5th. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.60 by $0.02. The firm's quarterly revenue was up .2% compared to the same quarter last year. Read the conference call transcript. When did Qiagen's stock split? Shares of Qiagen split on the morning of Wednesday, January 29th 2025.The 36-35 split was announced on Wednesday, January 22nd 2025. The newly issued shares were distributed to shareholders after the market closes on Tuesday, January 28th 2025. An investor that had 100 shares of stock prior to the split would have 103 shares after the split. Who are Qiagen's major shareholders? Top institutional investors of Qiagen include GAMMA Investing LLC. How do I buy shares of Qiagen? Shares of QGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Qiagen own? Based on aggregate information from My MarketBeat watchlists, some other companies that Qiagen investors own include NVIDIA (NVDA), Alibaba Group (BABA), Pfizer (PFE), Advanced Micro Devices (AMD), Alphabet (GOOG), Qualcomm (QCOM) and Boeing (BA). Company Calendar Last Earnings8/05/2026Today10/14/2026Next Earnings (Estimated)11/03/20269th Annual Evercore ISI HealthCONx Conference12/01/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 QGEN's financial health is in the Green zone, according to TradeSmith. QGEN has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:QGEN CIK1015820 Webwww.qiagen.com Phone(177) 355-6600Fax31-77-355-6658Employees5,654Year Founded1984Price Target and Rating Average Price Target for Qiagen$43.93 High Price Target$55.00 Low Price Target$38.60 Potential Upside/Downside-3.5%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)$1.95 Trailing P/E Ratio18.76 Forward P/E Ratio18.74 P/E Growth4.52Net Income$424.88 million Net Margins19.49% Pretax Margin21.99% Return on Equity14.47% Return on Assets8.34% Debt Debt-to-Equity Ratio0.48 Current Ratio2.85 Quick Ratio2.31 Sales & Book Value Annual Sales$2.09 billion Price / Sales4.49 Cash Flow$3.41 per share Price / Cash Flow13.35 Book Value$17.89 per share Price / Book2.55Miscellaneous Outstanding Shares206,070,000Free Float187,528,000Market Cap$9.38 billion OptionableOptionable Beta0.61 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NYSE:QGEN) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredYou’d Never Guess What Their European Chalet CostEric and Debbie, a couple in their 60s from Burbank, California, retired to a private chalet on a European cou...International Living | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qiagen With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
